Multimode Observation of Virus Capsid Assembly
病毒衣壳组装的多模式观察
基本信息
- 批准号:9116986
- 负责人:
- 金额:$ 45.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-03-14 至 2021-02-28
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsBiochemicalBiochemistryBiologyBoxingBuffersCapsidCapsid ProteinsCell Culture TechniquesCessation of lifeChargeChronic Hepatitis BComplexComputer SimulationCryoelectron MicroscopyCustomDNADataDetectionDevelopmentElectron MicroscopyEvolutionFamilyFluorescenceGenesGenomeHealthHepatitis B VirusHumanIn VitroIndianaInfectionInterventionIonsKineticsLeadMapsMass Spectrum AnalysisMicroscopyModelingMonitorNanotechnologyPathway interactionsPharmacologic SubstancePopulationProcessReactionResearchResearch PersonnelResolutionStructureStudy modelsTechniquesTechnologyTestingTherapeuticTimeUniversitiesVirusVirus AssemblyWorkbasecomputerized toolsdimerin vivoinhibitor/antagonistinstrumentlight scatteringmathematical modelmillisecondmutantnucleic acid localizationparticlepathogenreconstructionresearch studyself assemblysmall moleculetheoriesviral RNA
项目摘要
DESCRIPTION (provided by applicant): Self-assembling icosahedral capsids are found in about half of known virus families. Yet, the mechanisms of assembly remain a black box, even though assembly is fundamental to biology. For example, assembly is critical to, cellular localization, nucleic acid packaging, and new classes of assembly-directed antivirals (sometimes described as assembly inhibitors though they actually promote mis-assembly). To date, almost all observations of assembly have depended on ensembles of structurally ill-defined complexes. Similarly, almost all models of assembly have depended on ad hoc assumptions regarding the state of subunits in solution, the state of subunits in incomplete capsids, and the list of intermediates participating in assembly. We propose a detailed analysis of the assembly of Hepatitis B Virus (HBV). In vitro experiments, involving mutants and combinations of mutants will be validated by comparison to assembly in cell culture. Based on modeling studies we hypothesize that assembly of the 120-dimer T=4 HBV capsid will involve a relatively small number of intermediates. If this is the case it has immediate implications for the
organization of viral RNA, which in vivo is packaged during the assembly process. In this proposal we will characterize HBV capsid self-assembly using biochemical techniques and electron microscopy (Zlotnick, Wang labs), time resolved SAXS (Raviv Lab), and single particle observations by charge detection mass spectrometry (Jarrold Lab). Preliminary data show the feasibility of experiments and indicate the presence of some favored intermediates. These results will contribute to the development of mathematical models that faithfully replicate assembly and can help identify salient points for interfering with normal assembly. HBV is one the smallest human pathogens (3200 bp DNA genome) and one of the most widespread. About 350 million people have chronic HBV leading to about 600,000 deaths each year. Current therapeutics suppress but do not cure infection. Several pharmaceutical companies are investigating HBV capsid protein as an antiviral target with potential to achieve a functional cure
描述(由申请人提供):在大约一半的已知病毒家族中发现了自组装二十面体衣壳。然而,组装的机制仍然是一个黑匣子,即使组装是生物学的基础。例如,组装对于细胞定位、核酸包装和新类别的组装定向抗病毒药物(有时被描述为组装抑制剂,尽管它们实际上促进错误组装)至关重要。迄今为止,几乎所有的组装观测都依赖于结构不明确的复合物的集合。类似地,几乎所有的组装模型都依赖于关于亚基在溶液中的状态、亚基在不完整衣壳中的状态以及参与组装的中间体列表的特设假设。我们提出了一个详细的分析组装的B型肝炎病毒(HBV)。涉及突变体和突变体组合的体外实验将通过与细胞培养物中的组装进行比较来验证。基于建模研究,我们假设120-二聚体T=4 HBV衣壳的组装将涉及相对少量的中间体。如果是这样的话,
病毒RNA在体内的组装过程中被包装。在本提案中,我们将使用生物化学技术和电子显微镜(Zlotnick,Wang实验室),时间分辨SAXS(Raviv实验室)和电荷检测质谱(Jarrold实验室)的单颗粒观察来表征HBV衣壳自组装。初步数据表明实验的可行性,并表明存在一些有利的中间体。这些结果将有助于发展的数学模型,忠实地复制组装,并可以帮助确定干扰正常组装的突出点。HBV是人类最小的病原体之一(3200 bp DNA基因组),也是分布最广的病原体之一。每年约有3.5亿人患有慢性HBV,导致约60万人死亡。目前的治疗方法抑制但不能治愈感染。几家制药公司正在研究HBV衣壳蛋白作为抗病毒靶点,有可能实现功能性治愈
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam Zlotnick其他文献
Adam Zlotnick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam Zlotnick', 18)}}的其他基金
STRUCTURAL BASIS OF CONTROLLING VIRUS CAPSID ASSEMBLY
控制病毒衣壳组装的结构基础
- 批准号:
8171995 - 财政年份:2010
- 资助金额:
$ 45.28万 - 项目类别:
2010 Molecular Biology of Hepatitis B Viruses Meeting
2010年乙型肝炎病毒分子生物学会议
- 批准号:
7915035 - 财政年份:2010
- 资助金额:
$ 45.28万 - 项目类别:
相似海外基金
CAREER: Biochemical and Structural Mechanisms Controlling tRNA-Modifying Metalloenzymes
职业:控制 tRNA 修饰金属酶的生化和结构机制
- 批准号:
2339759 - 财政年份:2024
- 资助金额:
$ 45.28万 - 项目类别:
Continuing Grant
Systematic manipulation of tau protein aggregation: bridging biochemical and pathological properties
tau 蛋白聚集的系统操作:桥接生化和病理特性
- 批准号:
479334 - 财政年份:2023
- 资助金额:
$ 45.28万 - 项目类别:
Operating Grants
Diurnal environmental adaptation via circadian transcriptional control based on a biochemical oscillator
基于生化振荡器的昼夜节律转录控制的昼夜环境适应
- 批准号:
23H02481 - 财政年份:2023
- 资助金额:
$ 45.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Leveraging releasable aryl diazonium ions to probe biochemical systems
利用可释放的芳基重氮离子探测生化系统
- 批准号:
2320160 - 财政年份:2023
- 资助金额:
$ 45.28万 - 项目类别:
Standard Grant
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 45.28万 - 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
- 批准号:
10604822 - 财政年份:2023
- 资助金额:
$ 45.28万 - 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
- 批准号:
10716621 - 财政年份:2023
- 资助金额:
$ 45.28万 - 项目类别:
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
- 批准号:
10655891 - 财政年份:2023
- 资助金额:
$ 45.28万 - 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
- 批准号:
10621634 - 财政年份:2023
- 资助金额:
$ 45.28万 - 项目类别:
EAGER: Elastic Electronics for Sensing Gut Luminal and Serosal Biochemical Release
EAGER:用于感测肠腔和浆膜生化释放的弹性电子器件
- 批准号:
2334134 - 财政年份:2023
- 资助金额:
$ 45.28万 - 项目类别:
Standard Grant